Why Medtronic Stock Marched Higher on Monday
Medtronic (NYSE: MDT) stock was a fairly hot item as the trading week kicked off, with investors pushing the shares up by almost 3% in value. On Sunday, Medtronic published five-year data from a low-risk clinical trial of its Evolut transcatheter aortic valve replacement (TAVR) system. In the trial, TAVR, which assists patients suffering from the heart valve disorder aortic stenosis, was tested against surgical aortic vale replacement (SAVR).